Oncogenetics
Determining whether a hereditary cancer predisposition is present, is important for both the cancer patient and his family. It is relevant for surveillance and prevention or early detection of new tumours, treatment options and issues surrounding the desire to have children. For this reason, it must be ensured that for every patient with cancer (now or in the past) referral for genetic testing is considered. In this article we indicate how to take a family history and where to find and how to apply referral criteria if such a question arises in clinical practice. The consequences of a genetic diagnosis are illustrated by a breast cancer case.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:167 |
---|---|
Enthalten in: |
Nederlands tijdschrift voor geneeskunde - 167(2022) vom: 22. Dez. |
Sprache: |
Niederländisch |
---|
Weiterer Titel: |
Oncogenetica |
---|
Beteiligte Personen: |
Suerink, Manon [VerfasserIn] |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 13.01.2023 Date Revised 01.03.2023 published: Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM351440054 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM351440054 | ||
003 | DE-627 | ||
005 | 20231226051355.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||dut c | ||
028 | 5 | 2 | |a pubmed24n1171.xml |
035 | |a (DE-627)NLM351440054 | ||
035 | |a (NLM)36633037 | ||
035 | |a (PII)D6958 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a dut | ||
100 | 1 | |a Suerink, Manon |e verfasserin |4 aut | |
245 | 1 | 0 | |a Oncogenetics |
246 | 3 | 3 | |a Oncogenetica |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.01.2023 | ||
500 | |a Date Revised 01.03.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Determining whether a hereditary cancer predisposition is present, is important for both the cancer patient and his family. It is relevant for surveillance and prevention or early detection of new tumours, treatment options and issues surrounding the desire to have children. For this reason, it must be ensured that for every patient with cancer (now or in the past) referral for genetic testing is considered. In this article we indicate how to take a family history and where to find and how to apply referral criteria if such a question arises in clinical practice. The consequences of a genetic diagnosis are illustrated by a breast cancer case | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
700 | 1 | |a Bleiker, Eveline M A |e verfasserin |4 aut | |
700 | 1 | |a Nielsen, Maartje |e verfasserin |4 aut | |
700 | 1 | |a Houwink, Elisa J F |e verfasserin |4 aut | |
700 | 1 | |a Baas, Jara M |e verfasserin |4 aut | |
700 | 1 | |a Ausems, Margreet G E M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nederlands tijdschrift voor geneeskunde |d 1946 |g 167(2022) vom: 22. Dez. |w (DE-627)NLM000034231 |x 1876-8784 |7 nnns |
773 | 1 | 8 | |g volume:167 |g year:2022 |g day:22 |g month:12 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 167 |j 2022 |b 22 |c 12 |